Lupin stock rises over 2% on zero observations for Nagpur unit after USFDA inspection

Lupin stock rises over 2% on zero observations for Nagpur unit after USFDA inspection

Friday, September 14, 2018

Lupin announced the successful completion of an inspection carried out by the US Food and Drug Administration (FDA) at its Nagpur, Maharashtra facility.

For more information on Indian Share Market Tips For Tomorrow

and quick free trial click here > 911 133 9000

Visit http://www.epicresearch.co

Connect with our social media sites
Next
« Prev Post
Previous
Next Post »